Pesquisar
Repligen Corp
RGENAdicionar à lista de desejos
136.308USD
-0.692-0.51%
Horário de mercado （ET）Cotações atrasadas em 15 min
7.68BValor de mercado
149.22P/L TTM
Mais detalhes de Repligen Corp Empresa
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Informações de Repligen Corp
Código da empresaRGEN
Nome da EmpresaRepligen Corp
Data de listagemApr 29, 1986
CEOLoeillot (Olivier)
Número de funcionários1778
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 29
EndereçoBuilding 1, Suite 100
CidadeWALTHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02453
Telefone17814499560
Sitehttps://www.repligen.com/
Código da empresaRGEN
Data de listagemApr 29, 1986
CEOLoeillot (Olivier)
Executivos da empresa Repligen Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
92.82K
+1.07%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
40.05K
+8.56%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
5.44K
+18.30%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
5.01K
+19.84%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%
Mr. Tony John Hunt
Mr. Tony John Hunt
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
Independent Director
Independent Director
--
--
Mr. James R. Bylund
Mr. James R. Bylund
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Konstantin Konstantinov, Ph.D.
Dr. Konstantin Konstantinov, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
92.82K
+1.07%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
40.05K
+8.56%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
5.44K
+18.30%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
5.01K
+19.84%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%
Perguntas frequentes
Quem são os cinco principais acionistas de Repligen Corp?
Os cinco principais acionistas de Repligen Corp são: Ms. Karen A. Dawes
Quantas instituições possuem ações da Repligen Corp (RGEN)?
Em 2026Q1, 1067 instituições possuíam ações da Repligen Corp, com valor de mercado aproximado de 65.93M, representando 116.89% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -2643397.00.
Qual é a maior fonte de receita da Repligen Corp?
Em 2026Q1, o segmento de negócios Product revenue - Filtration products gerou a maior receita para Repligen Corp, totalizando 402.79M e representando 54.58% da receita total.
